Clinical Trial Update: Primary Thrombocythaemia 1 Trial [NA]

View source ↗

Summary

This is a completed status update for the Primary Thrombocythemia 1 clinical trial conducted by the University of Cambridge.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Essential Thrombocythemia
• Myeloproliferative Neoplasm

Snippet

Sponsor: University of Cambridge | Conditions: Thrombocythemia, Myeloproliferative Disorder | NA | Status: COMPLETED